Somatropin

Phase 3Completed

0 watching 0 views this week📈 Rising

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Adult Growth Hormone Deficiency

Conditions

Adult Growth Hormone Deficiency

Trial Timeline

Jan 1, 2003 → May 1, 2006

NCT ID

NCT00191360

About Somatropin

Somatropin is a phase 3 stage product being developed by Eli Lilly for Adult Growth Hormone Deficiency. The current trial status is completed. This product is registered under clinical trial identifier NCT00191360. Target conditions include Adult Growth Hormone Deficiency.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (4)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00191360	Phase 3	Completed	Jan 1, 2003	May 1, 2006	Adult Growth Hormone Deficiency
NCT00191529	Phase 3	Completed	Dec 1, 2002	Jun 1, 2007	Infant, Small for Gestational Age
NCT00406926	Phase 3	Completed	Aug 1, 1999	Aug 1, 2003	Turner Syndrome
NCT00490191	Approved	Completed	Jan 1, 1999	Jul 1, 2001	Hypopituitarism

Competing Products

20 competing products in Adult Growth Hormone Deficiency

See all competitors

Product	Company	Stage	Hype Score
BBP-398 + sotorasib	BridgeBio Pharma	Phase 1	30
Daridorexant + Placebo	Idorsia	Phase 1	28
SON-1010 (IL12-FHAB)	Sonnet BioTherapeutics	Phase 1	28
agenT-797	MiNK Therapeutics	Phase 1	25
Pegilodecakin	Eli Lilly	Phase 1	33
eFT226 + Sotorasib + Fulvestrant + Abemaciclib + Trastuzumab	eFFECTOR Therapeutics	Phase 1/2	33
Lazertinib(G001) + Lazertinib(G002)	Yuhan	Phase 1	33
Patritumab deruxtecan	Daiichi Sankyo	Phase 2	52
DJ-927 + capecitabine	Daiichi Sankyo	Phase 1	33
Valemetostat Tosylate	Daiichi Sankyo	Phase 2	52
Roxadustat	Astellas Pharma	Phase 1	33
ASP3325 + Placebo	Astellas Pharma	Phase 1	33
TRK-100STP	Astellas Pharma	Phase 1	33
Ensitrelvir	Shionogi	Phase 1	33
E6130 + Placebo	Eisai	Phase 1	33
E7389 + E7389 + E7389	Eisai	Phase 1	33
Eribulin Mesylate	Eisai	Phase 1	33
E2022 + E2022 + E2022 + E2022 + E2022	Eisai	Phase 1	33
Donepezil Hydrochloride + Donepezil Hydrochloride + Donepezil Hydrochloride + Donepezil Hydrochloride	Eisai	Phase 1	33
Donepezil Hydrochloride + Donepezil Hydrochloride + Donepezil Hydrochloride	Eisai	Phase 1	33

Other Products from Eli Lilly

Insulin Glargine + Insulin Lispro Premix (mid-mixture and low-mixture)Approved

Olanzapine + PlaceboApproved

exenatide and sitagliptin + exenatide and placeboApproved

Tirzepatide + PlaceboApproved

tadalafilApproved